Location: Home
  • search
  • go
  • Relate News
  • 2/6/2018TaiGen's New IV Antibiotic Nemonoxacin Gets Fast Track Designation in ...
  • 2/6/2018Xbrane Biopharma Licenses GnRH Analog Spherotide to CR Pharma in China
  • 2/6/2018Pfizer, DL Medicine Enter Drug Discovery Partnership
  • 2/6/2018South Korea's Pharmaceutical Export to China Jumped Nearly 400% in 201...
  • 2/5/2018Shanghai AIC Penalizes U.S.-China Joint Venture for Providing Overseas...
  • 2/5/2018More Provincial Governments Liberalize Non-essential Drug Use in Prima...
  • 2/2/2018Shanghai AIC Terminates Antimonopoly Investigation of the City's GPO S...
  • 2/2/2018Puma Biotech and CANbridge Enter Exclusive Licensing for NERLYNX (nera...
  • 2/2/2018Shanghai Pharma Completes Acquisition of Cardinal Health's China Busin...
  • 2/2/2018Recent Executive Moves
  • 1/31/2018BeiGene Initiates Global Phase 3 Trial of Anti-PD-1 Antibody Tislelizu...
  • 1/31/2018Financial-related Company News in Brief
  • 1/31/2018Novartis Launches Asthma Drug Xolair (omalizumab) in China
  • 1/30/2018Why Most Small Players May Not Survive China's Pharmaceutical Industry...
  • 1/30/2018WuXi Biologics and Aravive Biologics to Form Strategic Manufacturing C...
  • 1/30/2018CFDA Lays Out Eight Major Food and Drug Regulatory Tasks in 2018
  • 1/30/2018AmCham: U.S. Cos in China Increasingly Upbeat on Economy Despite Ongoi...
  • 1/30/2018CFDA and MOST Issue Joint Document for Promoting Food and Drug Innovat...
  • 1/30/2018Compliance in China: Key Considerations
  • 1/29/2018CFDA Issues First List of Drugs with Expired, Terminated or Invalidate...
  • 1/29/2018NHFPC Solicits Feedbacks on Proposed Measure to Eliminate Provisions i...
  • 1/25/2018CFDA Issues New Announcement (2018#9) for Clinical Data Self-Inspectio...
  • 1/25/2018Shanghai Pharma to Open R&D Unit in San Diego As It Looks for More...
  • 1/25/2018CFDA Issues Announcement on Applicability of Level 2 Guidelines of ICH
  • 1/25/2018China Issues New Policy to Reform GP Training and Incentive Mechanisms
  • 1/25/2018CFDA Issues the Technical Guidelines for Applications of Phase I New D...
  • 1/23/2018China Approves Numerous Reform Policies Including New Document for Gen...
  • 1/23/2018Ping An Ventures Led $100M Series A Financing for Cell Therapy Firm Tm...
  • 1/23/2018Clover Biopharma to Make Biosimilars in China with GE Facility
  • 1/23/2018Cardiome Announces Expanded Label for Aggrastat in China
  • Page:181/369 Total number of articles:11065: [First][<<] [179] [180] [181] [182] [183] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group